Growth Metrics

Vericel (VCEL) EBT Margin Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -2,817.00
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 1,558.00
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -683.00
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 2,688.00
10 Vericel 1.69 Bn 1.55 Bn 49.27 Mn 1,215.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1,215.00
Dec 31, 2025 -50.00
Sep 30, 2025 911.00
Jun 30, 2025 804.00
Mar 31, 2025 -1,394.00
Dec 31, 2024 479.00
Sep 30, 2024 710.00
Jun 30, 2024 205.00
Mar 31, 2024 1,073.00
Dec 31, 2023 912.00
Sep 30, 2023 835.00
Jun 30, 2023 1,327.00
Mar 31, 2023 153.00
Dec 31, 2022 372.00
Sep 30, 2022 -272.00
Jun 30, 2022 -1,480.00
Mar 31, 2022 -1,042.00
Dec 31, 2021 -1,857.00
Sep 30, 2021 -2,551.00
Jun 30, 2021 3,192.00
Mar 31, 2021 828.00
Dec 31, 2020 322.00
Sep 30, 2020 -19.00
Jun 30, 2020 3,430.00
Mar 31, 2020 -443.00
Dec 31, 2019 -74.00
Sep 30, 2019 1,803.00
Jun 30, 2019 -5,136.00
Mar 31, 2019 1,317.00
Dec 31, 2018 1,643.00
Sep 30, 2018 2,385.00
Jun 30, 2018 -764.00
Mar 31, 2018 7,922.00
Dec 31, 2017 307.00
Sep 30, 2017 2,869.00
Jun 30, 2017 2,226.00
Mar 31, 2017 -9,148.00
Dec 31, 2016 3,756.00
Sep 30, 2016 -1,608.00
Jun 30, 2016 -2,226.00
Mar 31, 2016 2,794.00
Dec 31, 2015 -1,626.00
Sep 30, 2015 3,996.00
Jun 30, 2015 17,562.00
Dec 31, 2014 6.15 Mn
Jun 30, 2014 17.43 Mn
Dec 31, 2013 -2.15 Mn
Mar 31, 2013 33.82 Mn
Mar 31, 2012 -35.84 Mn